News / Business
EiRx Therapeutics (LON:ERX) to Release Interim 2008 Earnings March 28
EiRx
Therapeutics (LON:ERX) will release the interim earnings for 2008 on Friday,
March 28.
EiRx
Therapeutics Plc is engaged in the discovery and development of novel
therapeutics for cancer treatment. The
company’s drug discovery is conducted in laboratories in
The company
aims to develop experimental cancer medicines for clinical testing before it is
licensed to a pharmaceutical development company. The company also engages in contract research
for third party pharmaceutical and therapeutics companies.
Auvation
Limited, involved in drug research and EiRx Therapeutics Limited, involed in
apoptosis research, are subsidiaries of the company.
EiRx
Therapeutics (LON:ERX)
For more
Earnings related events or to post your own events, visit:
